management team     management team geert kersten has served in his current leadership role at celsci since  mr kersten has been with celsci from the early days of its inception since  he has been involved in the pioneering field of cancer immunotherapy for almost two decades and has successfully steered celsci through many challenging cycles in the biotechnology industry mr kersten also provides celsci with significant expertise in the fields of finance and law and has a unique vision of how the companys multikine� product will change the way cancer is treated  prior to celsci mr kersten worked at the law firm of finley  kumble and worked at source capital an investment banking firm located in mclean va he is a native of germany graduated from millfield school in england and completed his studies in the us mr kersten completed his undergraduate degree in accounting received an mba from george washington university and a law degree jd from american university in washington dc mr kersten is also the inventor of a patent on the potential use of multikine in managing cholesterol patricia b prichep has over  years experience in business operations and administration she joined celsci in  and has been celscis senior vice president of operations since march  between december  and march  ms prichep was celscis director of operations ms prichep became celscis corporate secretary in may  she is responsible for all daytoday operations of the company including human resources and is the liaison with the auditing firm for financial reporting june  to december  ms prichep was the manager of quality and productivity for the nasds management systems and support department she was responsible for the internal auditing and work flow analysis of operations between  and  ms prichep was vice president and operations manager for source capital ltd she handled all operations and compliance for the company and was licensed as a securities broker ms prichep received her ba from the university of bridgeport in connecticut eyal talor joined celsci in october  in october  dr talor was promoted to chief scientific officer prior to this promotion dr talor was the senior vice president of research and manufacturing he is a clinical immunologist with over  years of handson management of clinical research and drug development for immunotherapy application preclinical to phase iii in the biopharmaceutical industry  his expertise includes biopharmaceutical rd and biologics product development gmp good manufacturing practices manufacture quality control testing and the design and building of gmp manufacturing and testing facilities  he served as director of clinical laboratories certified by the state of maryland and has experience in the design of clinical trials phase i  iii and gcp good clinical practices requirements  he also has broad experience in the different aspects of biological assay development analytical methods validation raw material specifications and qc quality control tests development under fdagmp usp and ich guidelines  he has extensive experience in the preparation of documentation for ind and other regulatory submissions  his scientific area of expertise encompasses immune response assessment  he is the author of over  publications and has published a number of reviews on immune regulations in relation to clinical immunology before coming to celsci he was director of rd and clinical development at cbl inc principal scientist  project director and clinical laboratory director at sra technologies inc prior to that he was a full time faculty member at the johns hopkins university medical intuitions school of public health  he has invented technologies which are covered by two us patents one on multikines composition of matter and method of use in cancer and one on a platform peptide technology adapt for the treatment of autoimmune diseases asthma allergy and transplantation rejection  he also is responsible for numerous product and process inventions as well as a number of pending us and pct patent applications  he received his phd in microbiology and immunology from the university of ottawa ottawa ontario canada and had postdoctoral training in clinical and cellular immunology at the johns hopkins university baltimore maryland usa  he holds an adjunct associate teaching position at the johns hopkins university medical institutions daniel h zimmerman phd is the senior vice president of research cellular immunology for celsci corporation and head of the leaps technology program  dr zimmerman has invented technologies which are covered by over a dozen us patents as well as many foreign equivalent patents he is the author of over  scientific publications in the area of immunology and infectious diseases he has been awarded numerous grants from nih and dod  from  dr zimmerman was a senior staff fellow at nih for the following  years he continued on at nih as a guest worker dr zimmerman received a phd in biochemistry in  a masters in zoology in  from the university of florida and a bs in biology from emory and henry college in  john cipriano is celscis senior vice president of regulatory affairs  mr cipriano brings to celsci over  years of experience in both biotech and pharmaceutical companies in addition he held positions at the united states food and drug administration fda as deputy director division of biologics investigational new drugs office of biologics research and review and was the deputy director ind branch division of biologics evaluation office of biologics  mr cipriano completed his bs in pharmacy from the massachusetts college of pharmacy in boston massachusetts he received his ms in pharmaceutical chemistry from purdue university in west lafayette indiana william brooke jones has been with celsci since  and has overall responsibility for quality assurance  mr jones began his career in biotechnology in  at the fort detrick nci frederick cancer research center where he was responsible for gmp compliance of fermentationbased clinical trial drug products used by the national cancer institute with nearly  years management experience in biotechnology at such companies as biogen and novartis mr jones brings significant experience both american and european in the areas of quality regulatory and validation in addition to his responsibilities at novartis in the us mr jones was also the director of quality control and quality assurance at the systemix facility in lyon france where he was involved in developing cell therapybased clinical trial products derived from the hematopoetic stem cell mr jones completed his undergraduate degree in biology at george mason university and his graduate degree course work in environmental biology at hood college todd s burkhart joined celsci corporation as vice president of manufacturingfacilities and commercial operations in january   mr burkhart has over  years of experience in the manufacture and process development of biologicals medical devices and other active pharmaceutical ingredients apis during his career in the pharmaceutical and biopharmaceutical industry and prior to joining celsci mr burkhart has been responsible for all aspects of gmp manufacturing and operations including production materials controls and facilities maintenance in addition he has extensive experience in the design of manufacturing facilities meeting fda gmp requirements mr burkhart has also been involved in the building andor running a number of major pharmaceutical facilities at companies such as cephalon human genome sciences and univax biologics  mr burkhart received his bs in biology from tusculum college greeneville tn     company code of ethics     products   patricia b prichep home search signinup contracts dictionary clauses companies people about faq blog follow patricia b prichep contracts click to signup for email updates loading home sample contracts by executive patricia b prichep patricia b prichep sec documents filings personal financials insider transactions previous companies celsci corporation amexcvm sample contracts with patricia b prichep celsci corporation – contract september nd  exhibit nnn employment agreement this employment agreement agreement is made by and between patricia b prichep employee and celsci corporation celsci or the company as of august   the effective date recitals employee has been an employee of celsci since december   celsci and employee wish to set forth in this agreement the terms and conditions under which employee is to be employed by celsci from the date of execution forward in consideration of employees agreement to continue providing services to celsci celscis agreement to employ employee on the terms and conditions set forth herein and the mutual agreements set forth herein the parties hereto agree as follows  term and nature of employment celsci hereby employs employee as senior vice president of operations of celsci commencing on the effective date of this agreeme celsci corporation – contract september nd  exhibit mmm employment agreement this employment agreement agreement is made by and between geert r kersten employee and celsci corporation celsci or the company as of august   the effective date recitals employee has been an employee of celsci since february  celsci and employee wish to set forth in this agreement the terms and conditions under which employee is to be employed by celsci from the date of execution forward in consideration of employees agreement to continue providing services to celsci celscis agreement to employ employee on the terms and conditions set forth herein and the mutual agreements set forth herein the parties hereto agree as follows  term and nature of employment celsci hereby employs employee as chief executive officer of celsci commencing on the effective date of this agreement celsci corporation – contract january th  exhibit  ggg this warrant and the shares of common stock issuable upon exercise hereof have not been registered under the securities act of  as amended the securities act or any state securities laws and may not be sold transferred or otherwise disposed of unless registered under the securities act and under applicable state securities laws or celsci corporation shall have received an opinion of its counsel that registration of such securities under the securities act and under the provisions of applicable state securities laws is not required warrant to purchase  shares of the common stock of celsci corporation series x expires january   date of issuance january   for val celsci corporation – third amendment to promissory note december th  celsci corporation – contract october rd  exhibit eee warrant agent agreement this agreement dated as of october   is between celsci corporation a colorado corporation the company and computershare inc a delaware corporation computershare and its wholly owned subsidiary computershare trust company na a federally chartered trust company together with computershare collectively the warrant agent whereas the company has previously sold to public investors warrants the warrants to purchase up to  shares of the companys common stock the common stock each warrant is exercisable to purchase one share of common stock upon the terms and conditions and subject to adjustment in certain circumstances all as set forth in this agreement whereas the company wishes to retain the warrant agent to act as warrant agent on behalf of the company and the warrant agent is willing so to act in conne celsci corporation – contract july th  celsci corporation exhibit ccc third amendment to promissory note june   on december   celsci corporation the company issued a promissory note the note to maximilian de clara or order the holder on april   the company signed a st amendment to the note due to the companys inability to repay the note on july   a nd amendment to the note was signed on august   the note was amended for the third time and restated in august  the note was transferred to the de clara trust the parties agree to further amend the note as follows  effective july   interest on the note will be at an annual rate of  and will be payable monthly  the maturity date of the note is extended to july    the note in whole or in part will be convertible at celsci corporation – contract may th  exhibit ccc warrant agent agreement this agreement dated as of may   is between celsci corporation a colorado corporation the company and computershare inc a delaware corporation computershare and its wholly owned subsidiary computershare trust company na a federally chartered trust company together with computershare collectively the warrant agent whereas the company has previously sold to public investors warrants the warrants to purchase up to  shares of the companys common stock the common stock each warrant is exercisable to purchase one share of common stock upon the terms and conditions and subject to adjustment in certain circumstances all as set forth in this agreement whereas the company wishes to retain the warrant agent to act as warrant agent on behalf of the company and the warrant agent is willing so to act in connectio celsci corporation – contract may th  exhibit ccc warrant agent agreement this agreement is between celsci corporation a colorado corporation the company and computershare inc a delaware corporation and its wholly owned subsidiary computershare trust company na a federally chartered trust company collectively the warrant agent whereas the company has sold to public investors warrants the warrants to purchase up to  shares of the companys common stock each warrant is exercisable to purchase one share of common stock upon the terms and conditions and subject to adjustment in certain circumstances all as set forth in this agreement whereas the company wishes to retain the warrant agent to act on behalf of the company and the warrant agent is willing so to act in connection with the issuance transfer exchange and replacement of the certificates evidencing the warrants to be issued under this agreement  celsci corporation – contract april th  exhibit ll warrant agent agreement this agreement dated as of   is between celsci corporation a colorado corporation the company and computershare inc a delaware corporation computershare and its wholly owned subsidiary computershare trust company na a federally chartered trust company collectively the warrant agent whereas the company proposes to sell to public investors warrants the series t warrants to purchase up to  shares of the companys common stock each warrant is exercisable to purchase one share of common stock upon the terms and conditions and subject to adjustment in certain circumstances all as set forth in this agreement whereas the company wishes to retain the warrant agent to act as warrant agent on behalf of the company and the warrant agent is willing so to act in connection with the issuance transfer exchange and replacement of the certific celsci corporation – contract august th  exhibit za amendment to employment agreement the parties hereto agree that section  of this companys employment agreement with geert r kersten be amended in its entirety to read as follows  involuntary termination for other than cause constructive termination constructive termination shall occur if employee resigns his employment within ninety  days of the occurrence of any of the following events i any reduction in the salary of the employee ii a relocation or demand for relocation of employees place of employment to a location more than thirtyfive  miles from employees current place of employment iii a significant and material reduction in employees authority job duties or level of responsibility or the imposition of significant and material limitations on employees autonomy in his position or iv if a ch celsci corporation – contract august th  exhibit j employment agreement this employment agreement agreement is made by and between patricia b prichep employee and celsci corporation celsci or the company as of august   the effective date recitals employee has been an employee of celsci since december   celsci and employee wish to set forth in this agreement the terms and conditions under which employee is to be employed by celsci from the date of execution forward in consideration of employees agreement to continue providing services to celsci celscis agreement to employ employee on the terms and conditions set forth herein and the mutual agreements set forth herein the parties hereto agree as follows  term and nature of employment celsci hereby employs employee as senior vice president of operations of celsci commencing on the effective date of this agreemen celsci corporation – contract may th  celsci corporation – contract december th  exhibit o lease agreement  maryland this lease agreement the lease is made as of the th day of june  by and between vif ii celsci partners llc a delaware limited liability company the landlord and celsci corporation a colorado corporation the tenant article  description of property  property subject to article  below landlord hereby leases to tenant and tenant leases from landlord pursuant to the terms conditions and uses herein set forth the property as used herein the property means the entire building commonly known as  the building and consisting of approximately  rentable square feet the premises together with the land upon which the building is located as more particularly described in exhibit a attached hereto the land article  term  lease term the term of this lease the lease term will be for a period of tw celsci corporation – contract september nd  exhibit j employment agreement this employment agreement agreement is made by and between patricia b prichep employee and celsci corporation celsci or the company as of august   the effective date recitals employee has been an employee of celsci since december   celsci and employee wish to set forth in this agreement the terms and conditions under which employee is to be employed by celsci from the date of execution forward in consideration of employees agreement to continue providing services to celsci celscis agreement to employ employee on the terms and conditions set forth herein and the mutual agreements set forth herein the parties hereto agree as follows  term and nature of employment celsci hereby employs employee as senior vice president of operations of celsci for a three  year period commencing on the effective celsci corporation – contract february th  exhibit w master production agreement this master production agreement this agreement is made as of this th day of june  between bio science contract production corp a maryland corporation bscp and celsci corporation  boone boulevard suite  vienna virginia a colorado corporation client recitals a bscp operates a multiclient production facility operated in accordance with the us food and drug administrations the fda current good manufacturing practices located at  east lombard street baltimore maryland  the facility b from time to time client desires to produce one or more products as hereinafter defined at the facility each product shall be described in a separate schedule a  each product produced pursuant to this agreement and the schedules hereto shall be separately sequentially numbered and identified beginning with  follow patricia b prichep contracts click to signup for email updates loading × have an account sign in here law insider recover your password no account register now no account register now sign in by using one of this services or forgot your password have an account sign in here join law insider for free by using one of this services or by registering you agree to our terms of service contract and agreement category list home search signinup contracts dictionary clauses companies people about faq blog sample contract categories a b c d e f g h i j k l m n o p q r s t u v w x y z abcdefghijklmnopqrstuvwxyz k delaware k new york k california k texas k agreement k nevada k florida k maryland k illinois k employment agreement k washington k amended and restated k massachusetts k new jersey k pennsylvania k georgia k colorado k ohio k minnesota k virginia k north carolina k incentive plan k credit agreement k amendment k connecticut k michigan k indiana k registration rights agreement k recitals k tennessee k arizona k missouri k purchase agreement k promissory note k indenture k warrant k louisiana k kansas k utah k wisconsin k oklahoma k securities purchase agreement k agreement and plan of merger k iowa k supplemental indenture k note k equity incentive plan k kentucky k stock purchase agreement k alabama × have an account sign in here law insider recover your password no account register now no account register now sign in by using one of this services or forgot your password have an account sign in here join law insider for free by using one of this services or by registering you agree to our terms of service patricia b prichep  alexandria va  intelius sign in we found patricia b prichep in alexandria va patricia b prichep intelius found that patricia b prichep is a female between  and  years old from alexandria va we have connected them to  addresses  phones and  relatives or associates get report now age patricia b prichep is in her s patricia has lived in alexandria va vienna va patricias relatives william prichep leslie prichep annette prichep paul henderson patricia b prichep zodiac signcapricorn genderfemale professional status senior vice president at celsci corporation get report now want to know more about patricia get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about patricia or use our people search engine to find others get background check on patricia b prichep get a criminal check on patricia b prichep get a public record report on patricia b prichep get a people search report on patricia b prichep patricia b pricheps contact information known cities lived in find out where patricia b prichep has lived as well as patricia b pricheps phone numbers and email addresses patricia b prichep has lived in  states virginia address for patricia b prichep  t d alexandria va has lived in alexandria va vienna va get full address report phone numbers associated with patricia b prichep    alexandria va    vienna va    vienna va get full phone report email addresses associated with patricia b prichep ppcom ppcom ppcom get email report patricia b pricheps professional information information regarding patricia b pricheps professional history find out previous places patricia b prichep has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act patricia b prichep has worked at  places company celsci corporation title senior vice president company hpproductionsinccom title senior partner patricia b pricheps experience title senior vice president company celsci corporation job details company size less than  mil  employee range  to less than  title senior partner company hpproductionsinccom job details company size less than  mil  employee range less than  additional professional information on patricia b prichep see patricia b pricheps linkedin profile patricia b pricheps social network and potential email matches find out potential social network profiles and potential email usernamed for patricia b prichep patricia b pricheps known social networks and potential email matches find all of patricia b pricheps social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches patricia prichep username matches patriciaprichep pricheppatricia patriciaprichep pricheppatricia patriciaprichep pricheppatricia patriciaprichep pricheppatricia pprichep popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches p prichep intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here prichep patricia b  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address     results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg pretpwins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  cvmcel sci corpcohealthbioprdbiological products no diagprichep patricia bosvppd  cvmcel sci corpcohealthbioprdbiological products no diagprichep patricia bosvppd  cvmcel sci corpcohealthbioprdbiological products no diagprichep patricia bosvppd  cvmcel sci corpcohealthbioprdbiological products no diagprichep patricia bosvp of opd  cvmcel sci corpcohealthbioprdbiological products no diagprichep patricia bosvppd dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved prichep patricia b top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active prichep patricia b • vienna va how do i update this listing prichep patricia b is based out of vienna whalewisdom has at least  insider transactions form  in our database for prichep patricia b summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from prichep patricia b enter your email address below and choose submit your email cancel contact info prichep patricia b  boone blvd  vienna va     business phone  sec sic codebiological products no disgnostic substances recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free unavailable  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries this feature is temporarily unavailable copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top bofi log in for events hafc an earn epam sn log in for events chkp lho fit gts find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  cvm stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventscvm cel sci corporation new    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade price history download to csv file download to excel file log in for more news expand all collapse all briefcelsci corp extends expiration date of its series dd warrants reuters –  am et  celsci corp cvm  celsci corp cvm  extending expiration date of its series dd warrants by one month from july   to august   source text for eikon further company coverage celsci extends the expiration date of series dd warrants issued in december  business wire –  am et  celsci corporation cvm announces that it is extending the expiration date of its series dd warrants by one month from july   to august   about celsci corporation cvm celscis cvm work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases briefcelsci receives letter from us fda reuters –  pm et  celsci corp cvm  says on june  received a letter from us fda in response to most recent june  submission  sec filing  celsci corp cvm  in letter fda requested that three additional changes be made to multikine investigator brochure that co submitted to fda on june   says fda provided instructions directing celsci cvm on what specific changes should be briefcelsci reports reverse stock split reuters –  pm et  celsci corp cvm  celsci cvm announces reverse stock split  celsci corp cvm  celsci cvm expects split to be implemented on june    celsci corp cvm  a for reverse split was authorized for its outstanding shares of common stock source text for eikon further company coverage celsci announces reverse stock split business wire –  pm et  celsci corporation cvm announced today that during its annual shareholders meeting on june   a for reverse split was authorized for its outstanding shares of common stock the cusip number for public warrants will remain the same and the warrants ticker symbol cvm ws will also remain unchanged celsci announces new data for its rheumatoid arthritis vaccine candidate published in peer reviewed journal business wire –  am et  cel therapeutic vaccine limits arthritis progression and demonstrates shift from a proinflammatory to an antiinflammatory environment in established animal models of ra celsci corporation cvm announces the publication of data from rheumatoid arthritis studies in vaccine a leading peerreviewed journal for researchers interested in vaccines and vaccination celsci extends the expiration date of series dd warrants issued in december  business wire –  am et  celsci corporation cvm announces that it is extending the expiration date of its series dd warrants by one month from june   to july   about celsci corporation cvm celscis cvm work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases briefcelsci submits fda response for its phase  head and neck cancer trial reuters –  am et  celsci corp cvm  celsci cvm submits fda response for its phase  head and neck cancer trial  celsci corp cvm   patients have been enrolled treated and are now being followed for studys primary endpoint  celsci cvm  hold issues addressed in fda communication were that studys investigator brochure and dear investigator letter need to be revised celsci submits fda response for its phase  head and neck cancer trial business wire –  am et   patients have been enrolled treated and are now being followed for studys primary endpoint celsci corporation cvm today announced that it has responded to the us food and drug administrations most recent communication from may  about the clinical hold imposed on the companys phase  head and neck cancer study with multikine the hold issues addressed in the fda communication were  celsci corporation releases letter to shareholders business wire –  am et  the following letter is being released by celsci corporation cvm to its shareholders dear fellow shareholders we are giving you an update on clinical hold communications with the us food and drug administration the agency regarding the previously announced partial clinical hold of celscis phase  clinical trial of its investigational drug multikine in patients with squamous cell carcino celsci scientist presents at aai  immunology  meeting business wire –  am et  celsci corporation cvm today announced that daniel zimmerman phd senior vice president of research cellular immunology presented additional data on its leaps rheumatoid arthritis vaccine candidates cel and cel at immunology  the annual meeting of the american association of immunologists may    in washington dc the title of his poster is key serum cytokine markers fo celsci announces change to the date of its annual meeting business wire –  pm et  celsci corporation cvm today announced it has changed the date for its annual meeting from june   to june   the companys annual meeting is now scheduled for monday june   at  am local time briefcelsci q loss per share  reuters –  pm et  celsci corp cvm  celsci corporation cvm reports second quarter fiscal year  financial results  q loss per share  source text for eikon further company coverage celsci corporation reports second quarter fiscal year  financial results business wire –  pm et  celsci corporation cvm today reported financial results for the quarter ended march   celscis cvm net loss available to common shareholders for the quarter ended march   was or per basic and diluted share versus or per basic and diluted share during the quarter ended march   during the six months ended march   the companys cash decreased by approximately  million briefcelsci announces  million registered direct offering reuters –  am et  celsci corp cvm  celsci cvm announces  million registered direct offering  celsci cvm  entered definitive agreement with one institutional investor for offering of shares of stock with proceeds of about  million in direct offering celsci announces  million registered direct offering business wire –  am et  celsci corporation cvm today announced it has entered into a definitive agreement with one institutional investor for an offering of shares of common stock with gross proceeds of approximately  million in a registered direct offering celsci receives intent to grant notice for new multikine patent from the european patent office business wire –  am et  celsci corporation cvm today announced that it has been notified that it will be granted a new patent on multikine its investigational cancer immunotherapy from the european patent office page page  todays and upcoming events aug  cvm to announce q earnings after market unconfirmed past events last  days jun  cvm split for  on  announce date  record date jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe secgems form  prichep patricia b  data feeds now available excel  csv  java  python etc database learn more prichep patricia b     ownership statement of changes in beneficial ownership insider trading  directors officers significant shareholders  filing date july   period ending june   date of filing date change july   signed by patricia prichep accession number  type  public document count  key documents and exhibits link type id filename primary document   primarydocxml issuer cel sci corp cvm reporting owner prichep patricia b officer sr vice president date of event req stmt  type title convexer price trans date deemed exe date trans form type trans code eqty swap footnote id trans timelines  shares value total value price  share acq or disp date exercisable expiration date  owned post trans value owned post trans underlying security title  underlying securities value underlying securities direct or indirect own nature indirect own nonderriv transcommon stocka  grant  awardfalsead signed by  patricia prichep  on  type filing company sic rel irs  state of inc fy end mailing address former filing vals issuer cel sci corp cik   boone blvd  suite  vienna  va     usa  biological products no disgnostic substances  usa  co    boone blvd suite  vienna  va     usa march  interleukin  inc type filing reporting owner company sic rel irs  state of inc fy end mailing address former filing vals reporting owner prichep patricia b  cik   cik form type act file number film number celsci corp cvm people  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states celsci corp cvm related topics stocksstock screenermarket datahealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse cvm on american stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  summary name age since current position geert kersten   chief executive officer treasurer director patricia prichep   senior vice president  operations corporate secretary john cipriano   senior vice president  regulatory affairs daniel zimmerman   senior vice president  research cellular immunology eyal talor   chief scientific officer alexander esterhazy   independent director peter young   independent director gavin windt ir contact officer » insider trading biographies name description geert kersten mr geert r kersten esq is chief executive officer treasurer director of celsci corporation since february  mr kersten has been with celsci from the early days of its inception since  he has been involved in the pioneering field of cancer immunotherapy for over two decades and has successfully steered celsci through many challenging cycles in the biotechnology industry mr kersten also provides celsci with significant expertise in the fields of finance and law and has a unique vision of how celscis multikine product could potentially change the way cancer is treated prior to celsci mr kersten worked at the law firm of finley  kumble and worked at source capital an investment banking firm located in mclean va he is a native of germany graduated from millfield school in england and completed his studies in the us mr kersten received his undergraduate degree in accounting and an mba from george washington university and a law degree jd from american university in washington dc patricia prichep ms patricia b prichep is senior vice president  operations corporate secretary of celsci corporation she joined celsci in  and has been celscis senior vice president of operations since march  between december  and march  ms prichep was celscis director of operations ms prichep became celscis corporate secretary in may  she is responsible for all daytoday operations of celsci including human resources and is the liaison with celscis independent registered public accounting firm for financial reporting from june  to december  ms prichep was the manager of quality and productivity for the nasds management systems and support department she was responsible for the internal auditing and work flow analysis of operations between  and  ms prichep was the vice president and operations manager for source capital ltd she handled all operations and compliance for source capital and was licensed as a securities broker ms prichep received her ba from the university of bridgeport in connecticut john cipriano mr john cipriano is senior vice president  regulatory affairs of celsci corporation he was celscis senior vice president of regulatory affairs between march  and december  and again since october  mr cipriano brings to celsci over  years of experience with both biotech and pharmaceutical companies in addition he held positions at the united states food and drug administration fda as deputy director division of biologics investigational new drugs office of biologics research and review and was the deputy director ind branch division of biologics evaluation office of biologics mr cipriano completed his bs in pharmacy from the massachusetts college of pharmacy in boston massachusetts and his ms in pharmaceutical chemistry from purdue university in west lafayette indiana daniel zimmerman dr daniel h zimmerman phd is senior vice president  research cellular immunology of celsci corporation he joined celsci in january  as the vice president of research cellular immunology dr zimmerman founded cellmed inc and was its president from  from  dr zimmerman served in various positions at electronucleonics inc his positions included scientist senior scientist technical director and program manager dr zimmerman held various teaching positions at montgomery college between  and  dr zimmerman has invented technologies which are covered by over a dozen us patents as well as many foreign equivalent patents he is the author of over  scientific publications in the area of immunology and infectious diseases he has been awarded numerous grants from nih and dod from  dr zimmerman was a senior staff fellow at nih for the following  years he continued on at nih as a guest worker dr zimmerman received a phd in biochemistry in  and a masters in zoology in  from the university of florida as well as a bs in biology from emory and henry college in  eyal talor dr eyal talor phd is chief scientific officer of celsci corporation he joined celsci in october  in october  dr talor was promoted to chief scientific officer prior to this promotion he was the senior vice president of research and manufacturing since march of  he is a clinical immunologist with over  years of handson management of clinical research and drug development for immunotherapy application preclinical to phase iii in the biopharmaceutical industry his experience includes biopharmaceutical rd and biologics product development gmp manufacture quality control testing and the design and building of gmp manufacturing and testing facilities he served as director of clinical laboratories certified by the state of maryland and has experience in the design of clinical trials phase i  iii and gcp requirements he also has broad experience in the different aspects of biological assay development analytical methods validation raw material specifications and qc quality control tests development under fdagmp usp and ich guidelines he has the experience in the preparation of documentation for ind and other regulatory submissions before coming to celsci he was director of rd and clinical development at cbl inc principal scientist  project director and clinical laboratory director at sra technologies inc prior to that he was a full time faculty member at the johns hopkins university medical intuitions school of public health he received his phd in microbiology and immunology from the university of ottawa ottawa ontario canada and had postdoctoral training in clinical and cellular immunology at the john hopkins university baltimore maryland usa he holds an adjunct associate teaching position at the johns hopkins university medical institutions alexander esterhazy mr alexander g esterhazy is an independent director of celsci corporation he has been a director of celsci since december  and has been an independent financial advisor since november  between july  and october  mr esterhazy was a senior partner of corpofina sa geneva a firm engaged in mergers acquisitions and portfolio management between january  and july  mr esterhazy was a managing director of dg bank in switzerland during this period mr esterhazy was in charge of the geneva switzerland branch of the dg bank founded and served as vice president of dg finance paris and was the president and chief executive officer of dgbourse a securities brokerage firm mr esterhazy brings extensive financial expertise that is valuable to celsci peter young dr peter r young phd is an independent director of celsci corporation dr young has been a senior executive within the pharmaceutical industry in the united states and canada for most of his career over the last  years he has primarily held positions of chief executive officer or chief financial officer and has extensive experience with acquisitions and equity financings since november  dr young has been the president of agnus dei llc which acts as a partner in an organization managing immune system clinics which treat patients with diseases such as cancer multiple sclerosis and hepatitis since january  dr young has been the president and chief executive officer of srl technology inc a company involved in the development of pharmaceutical drug delivery systems between  and  dr young was the chief financial officer of adams laboratories inc dr young received his phd in organic chemistry from the university of bristol england  and his bachelors degree in honors chemistry mathematics and economics also from the university of bristol england  celsci believes gavin windt basic compensation name fiscal year total geert kersten  patricia prichep  john cipriano  daniel zimmerman  eyal talor  alexander esterhazy  peter young  gavin windt  as of   sep  options compensation name options value geert kersten   patricia prichep   john cipriano   daniel zimmerman   eyal talor   alexander esterhazy   peter young   gavin windt   insider trading name shares traded price zimmerman daniel h phd   talor eyal   kersten geert r   prichep patricia b   kersten geert r   prichep patricia b   talor eyal   zimmerman daniel h phd   kersten geert r   talor eyal   zimmerman daniel h phd   prichep patricia b   talor eyal   kersten geert r   prichep patricia b   zimmerman daniel h phd   de clara maximilian d   cipriano john   prichep patricia b   kersten geert r   zimmerman daniel h phd   talor eyal   kersten geert r   talor eyal   zimmerman daniel h phd   » full list on insider trading related topics stocksstock screenermarket datahealthcarebiotechnology  medical research   patricia prichep   decypha sign in  welcome guest regions gcc  levant  mena  north africa gcc bahrain  kuwait  oman  qatar  saudi arabia  united arab emirates levant iraq  jordan  lebanon  palestine north africa egypt  libya  morocco  tunisia others iran  turkey  united kingdom  united states advanced search news markets companies research funds fixed income money markets commodities fx economics analysis more sign in membership customize your decypha logout welcome decypha alerts home people profiles people profile patricia prichep profile full name patricia prichep country biography patricia b prichep joined celsci in  and has been celscis senior vice president of operations since march  between december  and march designations date designation entity entity description country  celsci corporation   check all the individuals in check the list request a trial title select mr mrs ms miss dr prof first name last name job title select asset managers corporate banks investment managers wealth managers consultants  advisors legal practioners academics hedge funds private equity analysts traders equity research analysts phone company email country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe comments required fields   submit already registered login attempt was not successful please try again username email password enter characters   login forget your password by job title asset managers  corporate banks  investment managers  wealth managers  consultants  advisors  legal practitioners  academics  hedge funds  private equity analysts  traders  equity research analysts by scope equity  fixed income  funds  excel  analytical tools  markets  prices  money market  news  industry  ipos  mergers  acquisitions  commodities  economics covered countries and exchanges add your company   add yourself   terms and conditions   privacy policy   about directfn copyright  directfn all rights reserved data not available login login attempt was not successful please try again username email password enter characters forget your password back to top support  feedback ask for free trial request a trial title mr mrs ms miss dr prof first name last name email phone promo code country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe company job title select academics asset managers consultants  advisors corporate banks equity research analysts hedge funds investment managers legal practioners private equity analysts traders wealth managers comments required fields   submit contact us hello please use the below form for product support  feedback name   email  phone number   preferred contact method  email phone technical support x     slhopsdirectfnnet your account manager is   get a decypha membership to view this content get a decypha membership get the membership of decypha premium package to access more exciting features including advanced analytical tools and the pro  package pro  is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire all you need to access these valuable features is to click on the get a membership button and submit your details to our sales team upgrade your membership account is not entitled to view this information please contact your account manager to upgrade your membership email  supportdecyphacom register to view this content decypha free registration register free with decypha and get access to realtime price information and many other features including technical scanner fundamental screener etc just click the registration button submit your details and get registered for free microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates amazon prime interesting finds updated daily amazon try prime all all departments alexa skills amazon devices amazon video amazon warehouse deals appliances apps  games arts crafts  sewing automotive parts  accessories baby beauty  personal care books cds  vinyl cell phones  accessories clothing shoes  jewelry    women    men    girls    boys    baby collectibles  fine art computers courses credit and payment cards digital music electronics gift cards grocery  gourmet food handmade health household  baby care home  business services home  kitchen industrial  scientific kindle store luggage  travel gear luxury beauty magazine subscriptions movies  tv musical instruments office products patio lawn  garden pet supplies prime exclusive prime pantry software sports  outdoors tools  home improvement toys  games vehicles video games wine go departments en   hello sign inaccount  listssign inaccount  listsorderstry primecart your amazoncomtodays dealsgift cards  registrysellhelpdisability customer support theres a problem loading this menu right now learn more about amazon prime get fast free shipping with amazon prime prime members enjoy free twoday shipping and exclusive access to music movies tv shows original audio series and kindle books  get started fast free shipping and moreprime members also enjoy exclusive access to movies and tv shows adfree music kindle books original audio series and unlimited photo storage start your day prime free trial after your free trial amazon prime is just month cancel anytime see more plans › give the gift of prime  refer a friend  have a prime promo code fast free shipping on over  million eligible itemschoose from free twohour sameday or twoday delivery with prime need a last minute gift can’t get out of the house realize you forgot to pick up something with free twoday shipping and more from amazon prime your shopping problems are solved you get unlimited deliveries with no minimum order size and with millions of eligible items the options are practically limitless when shipping to select metro areas prime members also get free sameday delivery on over a million items and free hour delivery with prime now on daily essentials and groceries with free releasedate delivery on eligible preorder items you can enjoy highly anticipated books movies and video games as soon as possible learn more about all the prime shipping options enjoy instant access to video streaming prime includes popular movies and tv shows make every night a movie night with prime video your prime membership includes instant access to thousands of movies and tv shows at no additional cost catch amazon original series like golden globewinning transparent mozart in the jungle and goliath emmywinning man in the high castle or exciting and wildly popular the grand tour stream on select smart tvs roku xbox amazon fire tv iphones tablets and android devices download entertainment to your device to watch offline anywhere browse movies and tv shows over two million songs thousands of playlists and stations ondemand adfree music streaming prime music is a music streaming benefit featuring a growing selection of two million songs alexa voiceintegration and personalized recommendations at no additional cost with your amazon prime membership unlock even more music with amazon music unlimited plus get an exclusive prime member discount learn more books magazines  more unlimited reading on any device prime reading gives you unlimited access to over a thousand books current issue magazines books with audible narration comics kindle singles and more with access from any device – including your phone tablet or kindle – you can read however you want whenever you want learn more original audio series from audible unlimited listening to original audio series get hooked on original audio series from audible hunt for clues with intrepid investigators think big with bold visionaries or ‘keep it real’ with fearless comedians listen to insightful and engaging playlists handcrafted for every interest and refreshed daily drawing from news comedy shows articles talks and more whether you want to turn rush hour into an adventure with a great story or master a new topic while riding the train your commute will never be the same audible channels–from audible a world leader in audio entertainment learn more twitch prime get free game content every month exclusive discounts plus loads more get a member exclusive discount on new release and preorder boxed video games youll get characters vehicles skins and boosts for top games on twitch plus surprises like full indie games and exclusive loot you also receive adfree viewing and a free monthly twitch channel subscription to support your favorite streamer learn more all your photos together at last free unlimited photo storage your prime membership comes with free unlimited photo storage through prime photos which lets you securely save as many photos as you like and see them on your phone computer or tablet you can share this prime benefit and give free photo storage to up to five family members or friends collect photos together with your invited family and friends in the family vault and store memories from everyone in one safe place new photo search technology makes it easy to find specific photos by searching for things like “sunset” or “seattle” and your photos are organized automatically so it’s easy to find and enjoy them learn more prime rewards cardmembers earn  back with a prime credit card eligible prime members can earn  back at amazoncom using the amazon prime rewards visa card or the amazon prime store card all prime members earn  rewards on their debit spending with amazon prime reload learn more get early access minute early access to select amazon lightning deals consider yourself a techy the beststyled fashionista on the block or just an everyday savvy shopper be among the first to decide whats hot and whats not get minute early access to select lightning deals on amazon shop amazon lightning deals look for prime eligible items videos music and kindle books are clearly marked just look for the prime logo when you shop back to top get to know us careers about amazon investor relations amazon devices make money with us sell on amazon sell your services on amazon sell on amazon business sell your apps on amazon become an affiliate advertise your products selfpublish with us become an amazon vendor sell your subscription on amazon › see all amazon payment products amazon rewards visa signature cards amazoncom store card amazoncom corporate credit line shop with points credit card marketplace reload your balance amazon currency converter let us help you your account your orders shipping rates  policies amazon prime returns  replacements manage your content and devices amazon assistant help english united states amazon music stream millionsof songs amazon drive cloud storagefrom amazon pm score dealson fashion brands abebooks books art collectibles acx audiobook publishingmade easy alexa actionable analyticsfor the web amazon business everything foryour business   amazonfresh groceries  moreright to your door amazonglobal ship ordersinternationally home services handpicked proshappiness guarantee amazon inspire digital educationalresources amazon rapids fun stories forkids on the go amazon restaurants food delivery fromlocal restaurants amazon video direct video distributionmade easy   amazon web services scalable cloudcomputing services audible downloadaudio books audiobookstand discount audiobookson disc book depository books with freedelivery worldwide box office mojo find moviebox office data comixology thousands ofdigital comics createspace indie print publishingmade easy   dpreview digitalphotography east dane designer mensfashion fabric sewing quilting knitting goodreads book reviews recommendations imdb movies tv celebrities imdbpro get info entertainmentprofessionals need jungleecom shop onlinein india   kindle direct publishing indie digital publishingmade easy prime now free hour deliveryon everyday items prime photos unlimited photo storagefree with prime shopbop designerfashion brands tenmarkscom math activitiesfor kids  schools warehouse deals openboxdiscounts whispercast discover  distributedigital content     withoutabox submit tofilm festivals woot deals andshenanigans zappos shoes clothing souqcom shop online inthe middle east subscribe with amazon discover  trysubscription services   conditions of use privacy notice interestbased ads   amazoncom inc or its affiliates v robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates